Pfizer and BioNTech announced Tuesday that they're beginning a clinical trial for an Omicron-specific Covid-19 vaccine. Moderna had previously revealed plans to develop its own vaccine that targets the variant, which is by far the dominant one in the United States right now.
원문출처 : https://www.cnn.com/2022/01/27/health/omicron-booster-wait-wen-wellness/index.html
원문출처 : https://www.cnn.com/2022/01/27/health/omicron-booster-wait-wen-wellness/index.html